CIBC Asset Management
XLRN

CIBC Asset Management’s Acceleron Pharma XLRN Stock Holding History

CIBC Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,446
Closed -$421K – 1635
2021
Q3 		$421K Buy
2,446
+211
+9% +$27.6K ﹤0.01% 870
2021
Q2 		$280K Hold
2,235
– – ﹤0.01% 1041
2021
Q1 		$303K Buy
2,235
+159
+8% +$20.5K ﹤0.01% 958
2020
Q4 		$266K Hold
2,076
– – ﹤0.01% 969
2020
Q3 		$234K Buy
+2,076
New +$207K ﹤0.01% 943

CIBC Asset Management's XLRN Position: Q4 2021 in Review

CIBC Asset Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 2,446 shares — an estimated $421K sold.

CIBC Asset Management first reported a position in XLRN in Q3 2020 and held it in 5 quarters. The position peaked at $421K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • CIBC Asset Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • CIBC Asset Management sold 2,446 Acceleron Pharma shares in Q4 2021, an estimated $421K.
  • CIBC Asset Management first reported a position in Acceleron Pharma in Q3 2020 and held it in 5 quarters.
  • CIBC Asset Management's Acceleron Pharma position peaked at $421K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on CIBC Asset Management's 13F filing for Q4 2021, filed 8 Feb 2022.